Dactinomycin

Dactin

BrazilCancelledAuthorised 1 Nov 1996

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

CosmegenCanada · 0.5 MG / VIAL · Powder For Solution · Recordati Rare Diseases Canada INCSame substance
CosmegenItaly · Polvere per soluzione iniettabile · Recordati Rare Diseases SarlSame substance
BaxterNew Zealand · Inj 0.5 mg for ECPSame substance
CosmegenNew Zealand · Inj 0.5 mg vialSame substance
K. U. DACTINOMYCIN FOR INJECTION 0.5 mg/vialSingapore · 0.5 mg/vial · injection, powder, for solution · Shoei Universal Corporation Pte LTDSame substance
DactinomycinUnited States · 0.5MG/VIAL · injectable · HikmaSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Dactinomycin

Dactin

BrazilCancelledAuthorised 1 Nov 1996

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

CosmegenUnited States · 0.5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · Recordati Rare

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Dactinomycin
Register: Brazil (Anvisa)
Status: Cancelled
Status in the register: Inativo
Authorised: 1 Nov 1996
Registration: 112830032
Marketing authorisation holder: Laboratorio Itafarma Ltda
Procedure: Registered

CosmegenDactinomycinBrazilCancelled

K. U . DactinomycinDactinomycinBrazilCancelled